• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

London &Amp; Pacific Healthcare, Inc. To Assist UK's NanoBioDesign in Attracting Investment Funding

Posted on: Wednesday, 9 May 2007, 06:00 CDT

London & Pacific Healthcare, Inc. (PINKSHEETS: LDPH) ("London & Pacific," the "Company"), a corporate finance and development company working with a select group of healthcare enterprises, announced today that it has executed an agreement with NanoBioDesign, Ltd. ("NBD") of the United Kingdom. The Company will assist NBD in attracting investment capital from India.

Executive Chairman and CEO Stuart Bruck said, "We are pleased to have this chance to work with an exciting young company like NanoBioDesign. There are many companies in the Indian market looking to establish linkages with innovative companies in the Western markets, and London & Pacific can serve as an excellent bridge to these new relationships."

Dr. Stephen Collins, CEO of NanoBioDesign, said, "NBD is committed to bringing breakthrough technology to market in the next two years. The assistance of London & Pacific in attracting new funding will help us to advance our research and development programs."

About NanoBioDesign, Ltd.

NanoBioDesign, Ltd., with offices in London, United Kingdom, is a spin off from Imperial College, established to exploit the novel protein engineering approach of Professor Gilardi to the P450 family of liver enzymes. NBD has developed a test on an 8-well electrochemical platform using both wild type human P450s and polymorphic variants. This system will be used for testing the liver toxicity early in drug development, with the intention of reducing both the costs and the timelines for new drugs. It has been estimated that a 10% improvement in predicting the failure of drug candidates before they enter clinical trials could save an average of $100 million per drug (Source: U.S. Food & Drug Administration).

About London & Pacific Healthcare, Inc.

London & Pacific Healthcare, Inc., with offices in Los Angeles and London, operates three synergistic operating divisions that capitalize on emerging growth opportunities in the global healthcare industry. Its London-based division City & Westminster Advisers Limited provides comprehensive strategic and financial advisory services to healthcare start-ups, small and mid-sized organizations. Its two California-based divisions, HealthSPAC LLC, acts as an incubator for Special Purpose Acquisition Companies (SPACs), which are "blank check" companies that go public with the intention of merging or acquiring a company with the proceeds of an initial public offering, and Healthcare Fund Advisors LLC, provides specialized buy-side sourcing and analysis services to clients that invests in the global healthcare sector. For additional information, please visit the corporate website at www.lphealthcare.com.

Safe Harbour Disclaimer: This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as: the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels.

 Contact:  London & Pacific Healthcare, Inc. Michael K. Low 310-531-8226 mlow@lphealthcare.com  Investor Relations Kaiden Daniel IR Dennis Wilson 704-948-5348 dennis@kaidendaniel.com

SOURCE: London & Pacific Healthcare Inc.

Source: MARKET WIRE

More News in this Category